This implies a role for GSK3B in brain development as well as neurodegeneration, which may have important implications for the treatment of disorders such as Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease and schizophrenia, that have been associated with GSK3B. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.